HALO - Halozyme Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$103.00
DETAILS
HIGH:
$115.00
LOW:
$90.00
MEDIAN:
$105.00
CONSENSUS:
$103.00
DOWNSIDE:
4.32%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Greenblatt | 739,273 | $57.9M | 0.1% | -7,568 | DECREASED |
| Dalio | 463,146 | $36.3M | 0.1% | -48,283 | DECREASED |
| Cooperman | 28,200 | $2.2M | 0.0% | +7,300 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-08-14 | Appelhans Dannielle | director: | ? | -- | -- | -- |
| 2026-08-17 | Torley Helen | director, officer: PRESIDENT AND CEO | M-Exempt | 20,000 | $18.41 | $368K |
| 2026-08-18 | Torley Helen | director, officer: PRESIDENT AND CEO | M-Exempt | 20,000 | $18.41 | $368K |
| 2026-08-19 | Torley Helen | director, officer: PRESIDENT AND CEO | M-Exempt | 20,000 | $18.41 | $368K |
| 2026-08-17 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 2,100 | $101.77 | $214K |
| 2026-08-18 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 9,400 | $104.87 | $986K |
| 2026-08-17 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 500 | $100.46 | $50K |
| 2026-08-19 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 7,200 | $106.36 | $766K |
| 2026-08-17 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 9,000 | $102.55 | $923K |
| 2026-08-19 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 9,600 | $107.22 | $1.0M |
| 2026-08-18 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 5,703 | $103.08 | $588K |
| 2026-08-18 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 4,897 | $104.11 | $510K |
| 2026-08-17 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 900 | $98.96 | $89K |
| 2026-08-19 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 3,200 | $107.77 | $345K |
| 2026-08-17 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 7,500 | $103.48 | $776K |
| 2026-08-10 | Connaughton Bernadette | director | SELL | 1,626 | $102.80 | $167K |
| 2026-07-08 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 888 | $79.28 | $70K |
| 2026-07-08 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 1,035 | $80.19 | $83K |
| 2026-07-08 | Torley Helen | director, officer: PRESIDENT AND CEO | M-Exempt | 1,923 | $12.07 | $23K |
| 2026-06-30 | RAMSAY DAVID A | officer: EVP, PRESIDENT, DRUG DELIVERY | F-InKind | 5,408 | $78.27 | $423K |
| 2026-07-01 | Snellgrove Darren | officer: SVP, Chief Financial Officer | A-Award | 41,554 | -- | -- |
| 2026-07-01 | Connaughton Bernadette | director | SELL | 625 | $77.21 | $48K |
| 2026-07-01 | RAMSAY DAVID A | officer: EVP, PRESIDENT, DRUG DELIVERY | A-Award | 16,232 | -- | -- |
| 2026-07-01 | RAMSAY DAVID A | officer: EVP, PRESIDENT, DRUG DELIVERY | A-Award | 39,823 | $77.01 | $3.1M |
| 2026-07-01 | Connaughton Bernadette | director | SELL | 1,000 | $76.39 | $76K |